Oxygen-enhanced MRI MOLLI T1 mapping during chemoradiotherapy in anal squamous cell carcinoma
<p><strong>Background and Purpose:</strong><br /> Oxygen-enhanced magnetic resonance imaging (MRI) and T1-mapping was used to explore its effectiveness as a prognostic imaging biomarker for chemoradiotherapy outcome in anal squamous cell carcinoma.</p><br /> <...
Main Authors: | Bluemke, E, Bulte, D, Bertrand, A, George, B, Cooke, R, Chu, K-Y, Durrant, L, Goh, V, Jacobs, C, Ng, SM, Strauss, VY, Hawkins, MA, Muirhead, R |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Elsevier
2020
|
Similar Items
-
A prospective study of diffusion-weighted magnetic resonance imaging for predicting outcome following chemoradiotherapy, in squamous cell carcinomas of the anus
by: Muirhead, R, et al.
Published: (2019) -
A prospective study of diffusion-weighted magnetic resonance imaging as an early prognostic biomarker in chemoradiotherapy in squamous cell carcinomas of the anus
by: Muirhead, R, et al.
Published: (2020) -
Is there a role for a biological boost in squamous cell anal cancer?
by: Sabbagh, A, et al.
Published: (2018) -
Is there a role for an FDG derived biological boost in squamous cell anal cancer?
by: Sabbagh, A, et al.
Published: (2018) -
Oxygen-enhanced MRI and radiotherapy in patients with oropharyngeal squamous cell carcinoma
by: Bluemke, E, et al.
Published: (2022)